{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:02:43Z","timestamp":1785420163419,"version":"3.56.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-024-11258-6","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T15:09:47Z","timestamp":1734620987000},"page":"1337-1350","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Heterogeneity in response to neoadjuvant radiotherapy between soft tissue sarcoma histotypes: associations between radiology and pathology findings"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7259-6980","authenticated-orcid":false,"given":"Nicol\u00f2","family":"Gennaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"van der Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie J. M.","family":"Reijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester","family":"van Boven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petur","family":"Snaebjornsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise M.","family":"Bekers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhir","family":"Bodalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Trebeschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne M.","family":"Schrage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winette T. A.","family":"van der Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winan J.","family":"van Houdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick L. M.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yury S.","family":"Velichko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina G. H.","family":"Beets-Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Bruining","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"11258_CR1","unstructured":"IARC, WHO (2020) Soft tissue and bone tumours. WHO classification of tumours, 5th edn. IARC"},{"key":"11258_CR2","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1245\/s10434-017-6019-8","volume":"24","author":"AA Gingrich","year":"2017","unstructured":"Gingrich AA, Bateni SB, Monjazeb AM et al (2017) Neoadjuvant radiotherapy is associated with R0 resection and improved survival for patients with extremity soft tissue sarcoma undergoing surgery: a national cancer database analysis. Ann Surg Oncol 24:3252\u20133263. https:\/\/doi.org\/10.1245\/s10434-017-6019-8","journal-title":"Ann Surg Oncol"},{"key":"11258_CR3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ijrobp.2010.06.034","volume":"81","author":"S Sampath","year":"2011","unstructured":"Sampath S, Schultheiss TE, Hitchcock YJ et al (2011) Preoperative versus postoperative radiotherapy in soft-tissue sarcoma: multi-institutional analysis of 821 patients. Int J Radiat Oncol Biol Phys 81:498\u2013505. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.06.034","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11258_CR4","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/s0360-3016(00)00587-3","volume":"47","author":"KM Alektiar","year":"2000","unstructured":"Alektiar KM, Zelefsky MJ, Brennan MF (2000) Morbidity of adjuvant brachytherapy in soft tissue sarcoma of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys 47:1273\u20131279. https:\/\/doi.org\/10.1016\/s0360-3016(00)00587-3","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11258_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2478\/raon-2020-0012","volume":"54","author":"A Diamantis","year":"2020","unstructured":"Diamantis A, Baloyiannis I, Magouliotis DE et al (2020) Perioperative radiotherapy versus surgery alone for retroperitoneal sarcomas: a systematic review and meta-analysis. Radiol Oncol 54:14\u201321. https:\/\/doi.org\/10.2478\/raon-2020-0012","journal-title":"Radiol Oncol"},{"key":"11258_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.radonc.2015.12.002","volume":"119","author":"RLM Haas","year":"2016","unstructured":"Haas RLM, Miah AB, LePechoux C et al (2016) Preoperative radiotherapy for extremity soft tissue sarcoma; past, present and future perspectives on dose fractionation regimens and combined modality strategies. Radiother Oncol 119:14\u201321. https:\/\/doi.org\/10.1016\/j.radonc.2015.12.002","journal-title":"Radiother Oncol"},{"key":"11258_CR7","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/S0140-6736(02)09292-9","volume":"359","author":"B O\u2019Sullivan","year":"2002","unstructured":"O\u2019Sullivan B, Davis AM, Turcotte R et al (2002) Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 359:2235\u20132241. https:\/\/doi.org\/10.1016\/S0140-6736(02)09292-9","journal-title":"Lancet"},{"key":"11258_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13569-019-0115-4","volume":"9","author":"B Kasper","year":"2019","unstructured":"Kasper B (2019) The challenge of finding new therapeutic avenues in soft tissue sarcomas. Clin Sarcoma Res 9:5. https:\/\/doi.org\/10.1186\/s13569-019-0115-4","journal-title":"Clin Sarcoma Res"},{"key":"11258_CR9","doi-asserted-by":"crossref","unstructured":"Haas RL (2018) Preoperative radiotherapy in soft tissue sarcoma: from general guidelines to personalized medicine. Chin Clin Oncol 7:41","DOI":"10.21037\/cco.2018.05.02"},{"key":"11258_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.ejca.2012.10.002","volume":"49","author":"NJ Look Hong","year":"2013","unstructured":"Look Hong NJ, Hornicek FJ, Harmon DC et al (2013) Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study. Eur J Cancer 49:875\u2013883. https:\/\/doi.org\/10.1016\/j.ejca.2012.10.002","journal-title":"Eur J Cancer"},{"key":"11258_CR11","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1245\/s10434-010-1156-3","volume":"17","author":"RJ Canter","year":"2010","unstructured":"Canter RJ, Martinez SR, Tamurian RM et al (2010) Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcoma. Ann Surg Oncol 17:2578\u20132584. https:\/\/doi.org\/10.1245\/s10434-010-1156-3","journal-title":"Ann Surg Oncol"},{"key":"11258_CR12","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ejso.2010.05.021","volume":"36","author":"Y Miki","year":"2010","unstructured":"Miki Y, Ngan S, Clark JCM et al (2010) The significance of size change of soft tissue sarcoma during preoperative radiotherapy. Eur J Surg Oncol 36:678\u2013683. https:\/\/doi.org\/10.1016\/j.ejso.2010.05.021","journal-title":"Eur J Surg Oncol"},{"key":"11258_CR13","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.radonc.2010.10.007","volume":"97","author":"D Roberge","year":"2010","unstructured":"Roberge D, Skamene T, Nahal A et al (2010) Radiological and pathological response following pre-operative radiotherapy for soft-tissue sarcoma. Radiother Oncol 97:404\u2013407. https:\/\/doi.org\/10.1016\/j.radonc.2010.10.007","journal-title":"Radiother Oncol"},{"key":"11258_CR14","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ijrobp.2012.01.062","volume":"84","author":"RLM Haas","year":"2012","unstructured":"Haas RLM, Delaney TF, O\u2019Sullivan B et al (2012) Radiotherapy for management of extremity soft tissue sarcomas: Why, when, and where? Int J Radiat Oncol Biol Phys 84:572\u2013580. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.01.062","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11258_CR15","doi-asserted-by":"publisher","first-page":"e525","DOI":"10.1016\/j.ijrobp.2011.04.038","volume":"81","author":"D Wang","year":"2011","unstructured":"Wang D, Bosch W, Roberge D et al (2011) RTOG sarcoma radiation oncologists reach consensus on gross tumour volume and clinical target volume on computed tomographic images for preoperative radiotherapy of primary soft tissue sarcoma of extremity in Radiation Therapy Oncology Group studies. Int J Radiat Oncol Biol Phys 81:e525\u2013e528. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.04.038","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11258_CR16","doi-asserted-by":"publisher","unstructured":"Reijers SJM, Gennaro N, Bruining A et al (2023) Correlation of radiological and histopathological response after neoadjuvant radiotherapy in soft tissue sarcoma. Acta Oncol. https:\/\/doi.org\/10.1080\/0284186X.2023.2166427","DOI":"10.1080\/0284186X.2023.2166427"},{"key":"11258_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"11258_CR18","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","volume":"30","author":"A Fedorov","year":"2012","unstructured":"Fedorov A, Beichel R, Kalpathy-Cramer J et al (2012) 3D Slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging 30:1323\u20131341. https:\/\/doi.org\/10.1016\/j.mri.2012.05.001","journal-title":"Magn Reson Imaging"},{"key":"11258_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1148\/radiol.2512081403","volume":"251","author":"S Stacchiotti","year":"2009","unstructured":"Stacchiotti S, Collini P, Messina A et al (2009) High-grade soft-tissue sarcomas: tumour response assessment-pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria. Radiology 251:447\u2013456. https:\/\/doi.org\/10.1148\/radiol.2512081403","journal-title":"Radiology"},{"key":"11258_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejca.2015.09.021","volume":"53","author":"E Wardelmann","year":"2016","unstructured":"Wardelmann E, Haas RL, Bov\u00e9e JVMG et al (2016) Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting. Eur J Cancer 53:84\u201395. https:\/\/doi.org\/10.1016\/j.ejca.2015.09.021","journal-title":"Eur J Cancer"},{"key":"11258_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2307\/1412159","volume":"15","author":"C Spearman","year":"1904","unstructured":"Spearman C (1904) The proof and measurement of association between two things. Am J Psychol 15:72\u2013101. https:\/\/doi.org\/10.2307\/1412159","journal-title":"Am J Psychol"},{"key":"11258_CR22","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/j.ejso.2021.02.024","volume":"47","author":"S Bonvalot","year":"2021","unstructured":"Bonvalot S, Wunder J, Gronchi A et al (2021) Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: results of a retrospective multicenter study. Eur J Surg Oncol 47:2166\u20132172. https:\/\/doi.org\/10.1016\/j.ejso.2021.02.024","journal-title":"Eur J Surg Oncol"},{"key":"11258_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2018.05.007","volume":"69","author":"S Salah","year":"2018","unstructured":"Salah S, Lewin J, Amir E, Abdul Razak A (2018) Tumor necrosis and clinical outcomes following neoadjuvant therapy in soft tissue sarcoma: a systematic review and meta-analysis. Cancer Treat Rev 69:1\u201310. https:\/\/doi.org\/10.1016\/j.ctrv.2018.05.007","journal-title":"Cancer Treat Rev"},{"key":"11258_CR24","doi-asserted-by":"publisher","unstructured":"Spa\u0142ek MJ, Kozak K, Czarnecka AM et al (2020) Neoadjuvant treatment options in soft tissue sarcomas. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12082061","DOI":"10.3390\/cancers12082061"},{"key":"11258_CR25","doi-asserted-by":"publisher","first-page":"103309","DOI":"10.1016\/j.critrevonc.2021.103309","volume":"160","author":"N Gennaro","year":"2021","unstructured":"Gennaro N, Reijers S, Bruining A et al (2021) Imaging response evaluation after neoadjuvant treatment in soft tissue sarcomas: Where do we stand? Crit Rev Oncol Hematol 160:103309. https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103309","journal-title":"Crit Rev Oncol Hematol"},{"key":"11258_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jso.2930570208","volume":"57","author":"L Hew","year":"1994","unstructured":"Hew L, Kandel R, Davis A et al (1994) Histological necrosis in soft tissue sarcoma following preoperative irradiation. J Surg Oncol 57:111\u2013114. https:\/\/doi.org\/10.1002\/jso.2930570208","journal-title":"J Surg Oncol"},{"key":"11258_CR27","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1200\/JCO.2001.19.13.3203","volume":"19","author":"FC Eilber","year":"2001","unstructured":"Eilber FC, Rosen G, Eckardt J et al (2001) Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol 19:3203\u20133209. https:\/\/doi.org\/10.1200\/JCO.2001.19.13.3203","journal-title":"J Clin Oncol"},{"key":"11258_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1634\/theoncologist.2007-0220","volume":"13","author":"DR Lucas","year":"2008","unstructured":"Lucas DR, Kshirsagar MP, Biermann JS et al (2008) Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation. Oncologist 13:451\u2013458. https:\/\/doi.org\/10.1634\/theoncologist.2007-0220","journal-title":"Oncologist"},{"key":"11258_CR29","first-page":"3911","volume":"32","author":"D Shah","year":"2012","unstructured":"Shah D, Borys D, Martinez SR et al (2012) Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma. Anticancer Res 32:3911\u20133915","journal-title":"Anticancer Res"},{"key":"11258_CR30","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1002\/cncr.28945","volume":"120","author":"JT Mullen","year":"2014","unstructured":"Mullen JT, Hornicek FJ, Harmon DC et al (2014) Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy. Cancer 120:3676\u20133682. https:\/\/doi.org\/10.1002\/cncr.28945","journal-title":"Cancer"},{"key":"11258_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ijrobp.2017.02.087","volume":"98","author":"I-M Schaefer","year":"2017","unstructured":"Schaefer I-M, Hornick JL, Barysauskas CM et al (2017) Histologic appearance after preoperative radiation therapy for soft tissue sarcoma: assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response Score. Int J Radiat Oncol Biol Phys 98:375\u2013383. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.02.087","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11258_CR32","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/PAS.0000000000001922","volume":"46","author":"M Boxberg","year":"2022","unstructured":"Boxberg M, Langer R, Woertler K et al (2022) Neoadjuvant radiation in high-grade soft-tissue sarcomas: histopathologic features and response evaluation. Am J Surg Pathol 46:1060\u20131070. https:\/\/doi.org\/10.1097\/PAS.0000000000001922","journal-title":"Am J Surg Pathol"},{"key":"11258_CR33","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.ijrobp.2009.03.015","volume":"76","author":"DM MacDermed","year":"2010","unstructured":"MacDermed DM, Miller LL, Peabody TD et al (2010) Primary tumour necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys 76:1147\u20131153. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.03.015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11258_CR34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/bjc.2014.635","volume":"112","author":"D Andreou","year":"2015","unstructured":"Andreou D, Werner M, Pink D et al (2015) Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma. Br J Cancer 112:455\u2013460. https:\/\/doi.org\/10.1038\/bjc.2014.635","journal-title":"Br J Cancer"},{"key":"11258_CR35","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ejso.2014.01.011","volume":"40","author":"F le Grange","year":"2014","unstructured":"le Grange F, Cassoni AM, Seddon BM (2014) Tumour volume changes following pre-operative radiotherapy in borderline resectable limb and trunk soft tissue sarcoma. Eur J Surg Oncol 40:394\u2013401. https:\/\/doi.org\/10.1016\/j.ejso.2014.01.011","journal-title":"Eur J Surg Oncol"},{"key":"11258_CR36","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.ijrobp.2008.03.008","volume":"72","author":"RSA de Vreeze","year":"2008","unstructured":"de Vreeze RSA, de Jong D, Haas RL et al (2008) Effectiveness of radiotherapy in myxoid sarcomas is associated with a dense vascular pattern. Int J Radiat Oncol Biol Phys 72:1480\u20131487. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.03.008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11258_CR37","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1080\/02841860601080415","volume":"46","author":"K Engstr\u00f6m","year":"2007","unstructured":"Engstr\u00f6m K, Bergh P, Cederlund C-G et al (2007) Irradiation of myxoid\/round cell liposarcoma induces volume reduction and lipoma-like morphology. Acta Oncol 46:838\u2013845. https:\/\/doi.org\/10.1080\/02841860601080415","journal-title":"Acta Oncol"},{"key":"11258_CR38","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ijrobp.2004.03.009","volume":"60","author":"G Pitson","year":"2004","unstructured":"Pitson G, Robinson P, Wilke D et al (2004) Radiation response: an additional unique signature of myxoid liposarcoma. Int J Radiat Oncol Biol Phys 60:522\u2013526. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.03.009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11258_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.eclinm.2019.03.007","volume":"9","author":"A Gronchi","year":"2019","unstructured":"Gronchi A, Hindi N, Cruz J et al (2019) Trabectedin and radiotherapy in soft tissue sarcoma (TRASTS): results of a phase I study in myxoid liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups. EClinicalMedicine 9:35\u201343. https:\/\/doi.org\/10.1016\/j.eclinm.2019.03.007","journal-title":"EClinicalMedicine"},{"key":"11258_CR40","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.aott.2017.03.009","volume":"51","author":"A Salduz","year":"2017","unstructured":"Salduz A, Alpan B, Valiyev N et al (2017) Neoadjuvant radiotherapy for myxoid liposarcomas: oncologic outcomes and histopathologic correlations. Acta Orthop Traumatol Turc 51:355\u2013361. https:\/\/doi.org\/10.1016\/j.aott.2017.03.009","journal-title":"Acta Orthop Traumatol Turc"},{"key":"11258_CR41","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1002\/cncr.24375","volume":"115","author":"PWM Chung","year":"2009","unstructured":"Chung PWM, Deheshi BM, Ferguson PC et al (2009) Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas. Cancer 115:3254\u20133261. https:\/\/doi.org\/10.1002\/cncr.24375","journal-title":"Cancer"},{"key":"11258_CR42","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/jso.23322","volume":"107","author":"GO Delisca","year":"2013","unstructured":"Delisca GO, Alamanda VK, Archer KR et al (2013) Tumor size increase following preoperative radiation of soft tissue sarcomas does not affect prognosis. J Surg Oncol 107:723\u2013727. https:\/\/doi.org\/10.1002\/jso.23322","journal-title":"J Surg Oncol"},{"key":"11258_CR43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13566-012-0085-0","volume":"2","author":"A Betgen","year":"2013","unstructured":"Betgen A, Haas RLM, Sonke J-J (2013) Volume changes in soft tissue sarcomas during preoperative radiotherapy of extremities evaluated using cone-beam CT. J Radiat Oncol 2:55\u201362. https:\/\/doi.org\/10.1007\/s13566-012-0085-0","journal-title":"J Radiat Oncol"},{"key":"11258_CR44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3857\/roj.2018.00549","volume":"37","author":"C Gui","year":"2019","unstructured":"Gui C, Morris CD, Meyer CF et al (2019) Characterization and predictive value of volume changes of extremity and pelvis soft tissue sarcomas during radiation therapy prior to definitive wide excision. Radiat Oncol J 37:117\u2013126. https:\/\/doi.org\/10.3857\/roj.2018.00549","journal-title":"Radiat Oncol J"},{"key":"11258_CR45","doi-asserted-by":"publisher","first-page":"20210936","DOI":"10.1259\/bjr.20210936","volume":"95","author":"C Isaac","year":"2022","unstructured":"Isaac C, Kavanagh J, Griffin AM et al (2022) Radiological progression of extremity soft tissue sarcoma following pre-operative radiotherapy predicts for poor survival. Br J Radiol 95:20210936. https:\/\/doi.org\/10.1259\/bjr.20210936","journal-title":"Br J Radiol"},{"key":"11258_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13569-018-0106-x","volume":"8","author":"P Tsagozis","year":"2018","unstructured":"Tsagozis P, Brosj\u00f6 O, Skorpil M (2018) Preoperative radiotherapy of soft-tissue sarcomas: surgical and radiologic parameters associated with local control and survival. Clin Sarcoma Res 8:19. https:\/\/doi.org\/10.1186\/s13569-018-0106-x","journal-title":"Clin Sarcoma Res"},{"key":"11258_CR47","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2478\/raon-2023-0056","volume":"57","author":"MG De Lamarliere","year":"2023","unstructured":"De Lamarliere MG, Lusque A, Khalifa JA et al (2023) Management of tumour volume changes during preoperative radiotherapy for extremity soft tissue sarcoma: a new strategy of adaptive radiotherapy. Radiol Oncol 57:507\u2013515. https:\/\/doi.org\/10.2478\/raon-2023-0056","journal-title":"Radiol Oncol"},{"key":"11258_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejca.2015.12.008","volume":"56","author":"C Messiou","year":"2016","unstructured":"Messiou C, Bonvalot S, Gronchi A et al (2016) Evaluation of response after pre-operative radiotherapy in soft tissue sarcomas; the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) and Imaging Group recommendations for radiological examination and reporting with an emphasis on magnetic resonance imaging. Eur J Cancer 56:37\u201344. https:\/\/doi.org\/10.1016\/j.ejca.2015.12.008","journal-title":"Eur J Cancer"},{"key":"11258_CR49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1634\/theoncologist.13-S2-32","volume":"13","author":"SM Schuetze","year":"2008","unstructured":"Schuetze SM, Baker LH, Benjamin RS, Canetta R (2008) Selection of response criteria for clinical trials of sarcoma treatment. Oncologist 13:32\u201340. https:\/\/doi.org\/10.1634\/theoncologist.13-S2-32","journal-title":"Oncologist"},{"key":"11258_CR50","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejca.2016.05.023","volume":"64","author":"V Gr\u00fcnwald","year":"2016","unstructured":"Gr\u00fcnwald V, Liti\u00e8re S, Young R et al (2016) Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma\u2014an analysis of the EORTC 62012 study of the EORTC STBSG. Eur J Cancer 64:44\u201351. https:\/\/doi.org\/10.1016\/j.ejca.2016.05.023","journal-title":"Eur J Cancer"},{"key":"11258_CR51","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1159\/000518317","volume":"14","author":"AJ Lessing","year":"2021","unstructured":"Lessing AJ, Cote GM, DeLaney TF et al (2021) Pseudoprogression of malignant peripheral nerve sheath tumour in patient with neurofibromatosis type 1, a case report. Case Rep Oncol 14:1342\u20131346. https:\/\/doi.org\/10.1159\/000518317","journal-title":"Case Rep Oncol"},{"key":"11258_CR52","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.radcr.2018.05.013","volume":"13","author":"TA Vander Jagt","year":"2018","unstructured":"Vander Jagt TA, Davis LE, Thakur MD et al (2018) Pseudoprogression of CNS metastatic disease of alveolar soft part sarcoma during anti-PDL1 treatment. Radiol Case Rep 13:882\u2013885. https:\/\/doi.org\/10.1016\/j.radcr.2018.05.013","journal-title":"Radiol Case Rep"},{"key":"11258_CR53","doi-asserted-by":"publisher","first-page":"113261","DOI":"10.1016\/j.ejca.2023.113261","volume":"192","author":"L-R Howroyd","year":"2023","unstructured":"Howroyd L-R, Cornell I, Benson C et al (2023) Pseudoprogression in patients with uterine leiomyosarcoma treated with first-line single-agent doxorubicin. Eur J Cancer 192:113261. https:\/\/doi.org\/10.1016\/j.ejca.2023.113261","journal-title":"Eur J Cancer"},{"key":"11258_CR54","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1002\/cam4.2797","volume":"9","author":"P Martin-Romano","year":"2020","unstructured":"Martin-Romano P, Castanon E, Ammari S et al (2020) Evidence of pseudoprogression in patients treated with PD1\/PDL1 antibodies across tumour types. Cancer Med 9:2643\u20132652. https:\/\/doi.org\/10.1002\/cam4.2797","journal-title":"Cancer Med"},{"key":"11258_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-023-00580-9","volume":"23","author":"S M\u00f6nch","year":"2023","unstructured":"M\u00f6nch S, Heimer MM, Winkelmann M et al (2023) Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitors. Cancer Imaging 23:58. https:\/\/doi.org\/10.1186\/s40644-023-00580-9","journal-title":"Cancer Imaging"},{"key":"11258_CR56","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/jso.26306","volume":"123","author":"ND Klemen","year":"2021","unstructured":"Klemen ND, Kelly CM, Bartlett EK (2021) The emerging role of immunotherapy for the treatment of sarcoma. J Surg Oncol 123:730\u2013738. https:\/\/doi.org\/10.1002\/jso.26306","journal-title":"J Surg Oncol"},{"key":"11258_CR57","doi-asserted-by":"publisher","first-page":"5857","DOI":"10.1002\/cncr.27624","volume":"118","author":"S Stacchiotti","year":"2012","unstructured":"Stacchiotti S, Verderio P, Messina A et al (2012) Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy. Cancer 118:5857\u20135866. https:\/\/doi.org\/10.1002\/cncr.27624","journal-title":"Cancer"},{"key":"11258_CR58","doi-asserted-by":"publisher","unstructured":"Isaksson LJ, Summers P, Mastroleo F et al (2023) Automatic segmentation with deep learning in radiotherapy. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15174389","DOI":"10.3390\/cancers15174389"},{"key":"11258_CR59","doi-asserted-by":"publisher","first-page":"vdad027","DOI":"10.1093\/noajnl\/vdad027","volume":"5","author":"A Fathi Kazerooni","year":"2023","unstructured":"Fathi Kazerooni A, Arif S, Madhogarhia R et al (2023) Automated tumour segmentation and brain tissue extraction from multiparametric MRI of pediatric brain tumours: a multi-institutional study. Neurooncol Adv 5:vdad027. https:\/\/doi.org\/10.1093\/noajnl\/vdad027","journal-title":"Neurooncol Adv"},{"key":"11258_CR60","doi-asserted-by":"publisher","unstructured":"Moawad AW, Janas A, Baid U et al (2023) The brain tumour segmentation (BraTS-METS) challenge 2023: brain metastasis segmentation on pre-treatment MRI. Preprint at https:\/\/doi.org\/10.48550\/arxiv.2306.00838","DOI":"10.48550\/arxiv.2306.00838"},{"key":"11258_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-019-0206-8","volume":"19","author":"M Malek","year":"2019","unstructured":"Malek M, Rahmani M, Seyyed Ebrahimi SM et al (2019) Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI. Cancer Imaging 19:20. https:\/\/doi.org\/10.1186\/s40644-019-0206-8","journal-title":"Cancer Imaging"},{"key":"11258_CR62","doi-asserted-by":"publisher","unstructured":"Cohen J, Riishede I, Carlsen JF et al (2020) Can strain elastography predict malignancy of soft tissue tumours in a tertiary sarcoma center? Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics10030148","DOI":"10.3390\/diagnostics10030148"},{"key":"11258_CR63","doi-asserted-by":"publisher","unstructured":"Pepin K, Grimm R, Kargar S et al (2019) Soft tissue sarcoma stiffness and perfusion evaluation by MRE and DCE-MRI for radiation therapy response assessment: a technical feasibility study. Biomed Phys Eng Express. https:\/\/doi.org\/10.1088\/2057-1976\/ab2175","DOI":"10.1088\/2057-1976\/ab2175"},{"key":"11258_CR64","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1148\/radiol.2015142463","volume":"278","author":"T Soldatos","year":"2016","unstructured":"Soldatos T, Ahlawat S, Montgomery E et al (2016) Multiparametric assessment of treatment response in high-grade soft-tissue sarcomas with anatomic and functional MR imaging sequences. Radiology 278:831\u2013840. https:\/\/doi.org\/10.1148\/radiol.2015142463","journal-title":"Radiology"},{"key":"11258_CR65","doi-asserted-by":"publisher","first-page":"308","DOI":"10.18383\/j.tom.2016.00202","volume":"2","author":"W Huang","year":"2016","unstructured":"Huang W, Beckett BR, Tudorica A et al (2016) Evaluation of soft tissue sarcoma response to preoperative chemoradiotherapy using dynamic contrast-enhanced magnetic resonance imaging. Tomography 2:308\u2013316. https:\/\/doi.org\/10.18383\/j.tom.2016.00202","journal-title":"Tomography"},{"key":"11258_CR66","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.adro.2019.02.003","volume":"4","author":"MB Spraker","year":"2019","unstructured":"Spraker MB, Wootton LS, Hippe DS et al (2019) MRI radiomic features are independently associated with overall survival in soft tissue sarcoma. Adv Radiat Oncol 4:413\u2013421. https:\/\/doi.org\/10.1016\/j.adro.2019.02.003","journal-title":"Adv Radiat Oncol"},{"key":"11258_CR67","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ebiom.2019.08.059","volume":"48","author":"JC Peeken","year":"2019","unstructured":"Peeken JC, Spraker MB, Knebel C et al (2019) Tumor grading of soft tissue sarcomas using MRI-based radiomics. EBioMedicine 48:332\u2013340. https:\/\/doi.org\/10.1016\/j.ebiom.2019.08.059","journal-title":"EBioMedicine"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-11258-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-024-11258-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-11258-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:36:40Z","timestamp":1739903800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-024-11258-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":67,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["11258"],"URL":"https:\/\/doi.org\/10.1007\/s00330-024-11258-6","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Prof. Regina G. H. Beets-Tan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"R.G.H.B.-T. is a member of the Scientific Editorial Board of European Radiology (section: oncology). As such, they have not participated in the selection nor review processes for this article. The remaining authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Yury S. Velichko, PhD (co-author) provided statistical advice for this manuscript. No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The present work builds upon a previous study by our group, which was limited to comparing RECIST- and Choi-based response assessments and their correlation with pathology findings and clinical outcomes (Reijers et al [], ).","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}